Viewing Study NCT03515057


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2025-12-29 @ 6:45 PM
Study NCT ID: NCT03515057
Status: UNKNOWN
Last Update Posted: 2021-02-24
First Post: 2018-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics
Sponsor: Massachusetts General Hospital
Organization:

Study Overview

Official Title: Screening for Atrial Fibrillation in an Ambulatory Clinic Population: The VITAL-AF Study
Status: UNKNOWN
Status Verified Date: 2021-02
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VITAL-AF
Brief Summary: The overall goal of this study is to assess the effectiveness of screening for undiagnosed atrial fibrillation (AF) using simple, efficient, and portable electronic health and mobile technologies in a healthcare system. The investigators propose to perform population-based screening for undiagnosed AF as part of usual care in patients ≥ 65 years when their vital signs are checked (spot-check) at scheduled outpatient visits in adult Massachusetts General Hospital (MGH) primary care clinics. Patients will receive routine care by their primary care provider (PCP) based upon the results of the screening during the visit.

The investigators hypothesize that rates of AF detection among individuals ≥ 65 years in the MGH primary care network will be greater among patients in clinics assigned to the spot-check arm compared to patients in clinics assigned to the usual care arm of the study.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: